A typical neuroleptics seen to increase the risk of diabetes mellitus somewhat

NEW YORK (Reuters Health) - Younger patients with schizophrenia are more likely to be diagnosed with diabetes if they are treated with an atypical neuroleptic drug as opposed to a conventional neuroleptic, data from a Veterans Health Administration study indicate.

Dr. Michael J. Sernyak, of the VA Connecticut Healthcare System in West Haven, and associates identified more than 38,000 patients treated for schizophrenia in the Veterans Health Administration system for whom an antipsychotic drug was prescribed between June and September of 1999. Almost 60% were being treated with a typical agents, the investigators report in The American Journal of Psychiatry for April.